509: Garcia JA, Elson P, Tyler A, Triozzi P, Dreicer R. Sargramostim (GM-CSF) and
lenalidomide in castration-resistant prostate cancer (CRPC): results from a phase
I-II clinical trial. Urol Oncol. 2014 Jan;32(1):33.e11-7. doi:
10.1016/j.urolonc.2012.12.004. Epub 2013 Mar 17. PubMed PMID: 23510862.


510: Garcia JA, Rini BI. Castration-resistant prostate cancer: many treatments,
many options, many challenges ahead. Cancer. 2012 May 15;118(10):2583-93. doi:
10.1002/cncr.26582. Epub 2011 Oct 28. Review. PubMed PMID: 22038761.


511: Garcia JA. Sipuleucel-T in patients with metastatic castration-resistant
prostate cancer: an insight for oncologists. Ther Adv Med Oncol. 2011
Mar;3(2):101-8. doi: 10.1177/1758834010397692. PubMed PMID: 21789160; PubMed
Central PMCID: PMC3126040.


512: Garcia JA, Dreicer R. Immunotherapy in castration-resistant prostate cancer:
integrating sipuleucel-T into our current treatment paradigm. Oncology (Williston
Park). 2011 Mar;25(3):242-9. PubMed PMID: 21548467.